Literature DB >> 18068850

Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings.

Ekihiro Seki1, Yuichi Kondo, Yuji Iimuro, Tetsuji Naka, Gakuhei Son, Tadamitsu Kishimoto, Jiro Fujimoto, Hiroko Tsutsui, Kenji Nakanishi.   

Abstract

BACKGROUND/AIMS: As conditional knockout mice for stat3 are impaired in liver regeneration after partial hepatectomy while those for gp130 have defects in early STAT3 phosphorylation but have normal DNA synthesis, late STAT3 phosphorylation induced independently of gp130 seems to be essential for liver regeneration. Since HGF and EGF can activate STAT3 via gp130-independent MET and EGFR, respectively, we assumed that these factors account for STAT3-dependent liver regeneration. Here, we investigated this hypothesis by introducing suppressor of cytokine signaling (SOCS)-1 and SOCS3, potent negative regulators of STAT3 signaling, selectively in hepatocytes.
METHODS: We generated recombinant adenoviruses expressing socs1 and socs3.
RESULTS: Hepatocytes infected with socs1-virus lacked STAT3 phosphorylation in response to IL-6 and HGF, while cells infected with socs3-virus lacked the response to all of IL-6, HGF and EGF, indicating that those SOCS proteins differently regulate EGFR signaling. Mice infected with socs3-virus exhibited severe and persistent impairment while those with socs1-virus showed only delayed regeneration, indicating requirement of both MET and EGFR signalings.
CONCLUSIONS: These results clearly demonstrated that MET- and EGFR-mediated STAT3 signalings cooperatively contribute to liver regeneration and could provide new insights into tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068850     DOI: 10.1016/j.jhep.2007.08.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

Review 1.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

2.  Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

Authors:  Y Gui; M Yeganeh; Y-C Donates; W-S Tobelaim; W Chababi; M Mayhue; A Yoshimura; S Ramanathan; C Saucier; S Ilangumaran
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

3.  Toll-like receptor 4 and myeloid differentiation factor 88 provide mechanistic insights into the cause and effects of interleukin-6 activation in mouse liver regeneration.

Authors:  Javier Vaquero; Jean S Campbell; Jamil Haque; Ryan S McMahan; Kimberly J Riehle; Renay L Bauer; Nelson Fausto
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

4.  Meloxicam increases epidermal growth factor receptor expression improving survival after hepatic resection in diet-induced obese mice.

Authors:  Xiaoling Jin; Teresa A Zimmers; Yanlin Jiang; Daniel P Milgrom; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Surgery       Date:  2018-02-01       Impact factor: 3.982

5.  RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats.

Authors:  Shirish Paranjpe; William C Bowen; George C Tseng; Jian-Hua Luo; Anne Orr; George K Michalopoulos
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

6.  Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.

Authors:  M Yeganeh; Y Gui; R Kandhi; D Bobbala; W-S Tobelaim; C Saucier; A Yoshimura; G Ferbeyre; S Ramanathan; S Ilangumaran
Journal:  Oncogene       Date:  2016-01-04       Impact factor: 9.867

7.  Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.

Authors:  Run-Xuan Shao; Leiliang Zhang; Lee F Peng; Eileen Sun; Woo Jin Chung; Jae Yong Jang; Wei-Lun Tsai; Guibenson Hyppolite; Raymond T Chung
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

8.  Epidermal growth factor receptor restoration rescues the fatty liver regeneration in mice.

Authors:  Teresa A Zimmers; Xiaoling Jin; Zongxiu Zhang; Yanlin Jiang; Leonidas G Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

9.  Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.

Authors:  Xiaoling Jin; Teresa A Zimmers; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Dig Dis Sci       Date:  2018-10-03       Impact factor: 3.199

10.  SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.

Authors:  Minoru Fujimoto; Tetsuji Naka
Journal:  Gastroenterol Res Pract       Date:  2010-09-02       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.